GeoVax utilizes two robust core technology platforms:

• Modified Vaccinia Ankara (MVA) for creating vaccines for the prevention of various infectious diseases.

• Gene-Directed Enzyme Prodrug Therapy (GDEPT) for the treatment of solid tumors with an initial focus on head and neck cancer.